The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP).
 
Christopher Sweeney
Stock and Other Ownership Interests - BIND Biosciences; Leuchemix
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BIND Biosciences; Genentech/Roche; Janssen Biotech; Sanofi
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Janssen Biotech (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination
 
Wanling Xie
No Relationships to Disclose
 
Meredith M. Regan
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); OncoGenex (Inst); Pfizer (Inst); Veridex (Inst)
 
Mari Nakabayashi
No Relationships to Disclose
 
Marc E. Buyse
Employment - IDDI
Stock and Other Ownership Interests - IDDI
 
Noel W. Clarke
No Relationships to Disclose
 
Laurence Collette
No Relationships to Disclose
 
James J. Dignam
No Relationships to Disclose
 
Karim Fizazi
Honoraria - Astellas Pharma; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Curevac; ESSA; Janssen Oncology; Novartis; Orion; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Amgen
 
Muriel Habibian
No Relationships to Disclose
 
Susan Halabi
Consulting or Advisory Role - Bayer; Genentech/Roche
Travel, Accommodations, Expenses - Bayer
 
Philip W. Kantoff
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; Blend Therapeutics; Metamark Genetics; Placon
Consulting or Advisory Role - Astellas Pharma; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; BIND Biosciences; Blend Therapeutics; Cristal Therapeutics; Endocyte; Genentech/Roche; GTx; Ipsen; Janssen; Medivation; Merck; Metamark Genetics; Millennium; MorphoSys; MorphoSys; MTG Therapeutics; Omnitura; OncoCellMDX; Oncogenex; Pfizer; Sanofi; Sotio; Tokai Pharmaceuticals
Research Funding - Amgen (Inst); Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Bayer (Inst); Dendreon (Inst); Exelixis (Inst); Janssen (Inst); Medivation (Inst); Oncogenex (Inst); Sanofi (Inst)
Expert Testimony - Janssen; Sanofi
Travel, Accommodations, Expenses - Bavarian Nordic; BIND Biosciences; Janssen; Millennium; Sanofi
 
Wendy R. Parulekar
No Relationships to Disclose
 
Howard M. Sandler
Honoraria - Varian Medical Systems
Consulting or Advisory Role - Blue Earth Diagnostics; Eviti; Ferring; Janssen; Medivation/Astellas; Sanofi
Other Relationship - Caribou Publishing
 
Oliver Sartor
No Relationships to Disclose
 
Howard R. Soule
No Relationships to Disclose
 
Matthew Robert Sydes
Honoraria - Lilly
Research Funding - Astellas Pharma; Janssen-Cilag; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Lilly
 
Bertrand F. Tombal
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Sanofi; Steba Biotech; Takeda
Speakers' Bureau - Amgen; Janssen
Research Funding - Ferring (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi
 
Scott G. Williams
No Relationships to Disclose